Really wish someone would put something useful on this board. Are we just stuck to see how earnings call goes 8/3?? Does anyone have some insight?? Nothing is looking good here for longs.
The data is strong with their weight loss drugs, the new drug in the pipeline looks very promising, the sales data is trending upward ahead of projections, they are spreading globally... what more needs to be said? Patience will pay off.
Perhaps a short-term pull back is more likely before the next rally on OREX? if you guys have questions you should ask awe.SOME-StockS. They often respond to my emails which is helpful.
pops or homo
what a turd of a stock and a message board ..drops big.. no reason or chirps from anyone...this is a pos. bk or someone is going to jail
TAKE the BUYOUT--------OREX needs cash to promote sales , a large pharma could push sales up -400--500 %---SELL for $7----$8-------
Short term Dumping---??? push down because good news coming ??? OR large holder is getting OUT ? TV adds -sales reps --show us the numbers
Monster Microcaps Alert to OREX shareholders. Clean Energy Technologies - CETY - price today $.018. Price target $.20 by year end. Clean Energy Technologies. CETY recently announced expansion with their Europe Sales and Service Center for Europe new sales and to serve 65 existing customers with CETY’s General Electric clean energy Heat Recovery Systems and just announced they have already sold the first of SEVERAL HUNDRED units to come SOON.
Each CETY Heat Recovery System sells for $300,000 and market demand is several BILLION DOLLARS.
CETY purchased Heat Recovery Systems Division from General Electric and products are now very attractive to huge unmet markets and can achieve over $250 million annual sales within the next 2 years. Demand for conversion of wasted heat to electrical energy in big applications is VERY LARGE AND UNMET.
Clean Energy Technologies, Inc. Secures New Order for Waste Biomass Application in Europe
COSTA MESA, Calif., July 12, 2017 /PRNewswire/ -- Clean Energy Technologies, Inc. (CETY) announced today that its subsidiary Heat Recovery Solutions has secured a new Clean CycleTM generator order for a Waste Biomass application in Europe. Growing d
Shorts in control.......6000 shares trade ? one day this POS will pop to $5
Option traders visit CreditSpreads.io, zero cost live table of statistically gainful option credit spreads for the following 4 weeks, sometimes including spreads for OREX! High-probability option credit spreads present a solution to invest with specified risk and the maximum profit received right away. CreditSpreads.io targets only the spreads which fulfill its stringent requirements for probability and profit, and contributes to sustained profitability by telling you of any upcoming events which can affect the trade. www.creditspreads.io
Sustainable, high probability, defined risk stock option trading opportunities.
Mike about to be delisted...Market cap less then my family net worth Beahhhhhhh OREX BK
I'm not smart enough to understand how OREX drops $.09 and then goes up $.20 on this low volume today.... Love to be a student if anyone has the answer.
To all those who are losing money in this, just keep in mind it will be significantly profitable in 2018. Just hang in there! It is the best in class and may even get approval for cardiovascular benefits.
IGXT (MC $46 M) NDA filing for MEGA thin-flim Cialis (better than Viagra) this month =10++ BAGGER Potential ! PLEASE read this guys and then join us to make big money .A LIFETIME OPPORTUNITY HERE GUYS !!!
2 US-NDA submission within 2 months ,lot of Cash and heavily underpriced at a valuation of just $46 million .1 Big drug partnered with Endo Pharma already under review by FDA market launch expected in 1H 2018 .Load up guys before she the MEGA news hit the wire and thank me later .GL
MarketCap $46 Million Cash ~$12 Million (including convertible debt) =cash untill 2021+ Price: 0.70
NDA submission for tadalafil (erectile dysfunction) thin-film version of Blockbuster drug Cialis in June or July NDA resubmission for Rizaport (migraine) in early Q3 Partnership for Tadalafil in 2H 2017
IntelGenx previously confirmed the bioequivalence of Tadalafil to Eli Lilly’s Cialis, which had sales of $1.5-billion in 2016 but faces generic competition in 2020. IntelGenx has an exclusive license for oral films from Lilly for its dosing patent, which would allow Tadalafil to enter the ED market in the U.S. free from patent litigation from Lilly. Dr. Matzen explains that Tadalafil, which offers a discrete dosing alternative, could enter the market in 2018, with up to three years of market exclusivity before Cialis is hit with generic competition.
Tadalafil is an erectile dysfunction (ED) treatment that boasts bioequivalence with Cialis, the current leading brand, and with a successful biostudy in-hand a 505(b)(2) NDA is set to be filed any day now, meaning that a full launch should be expected in mid-2018. Cialis is already winning-out over Viagra in terms of numbers of prescriptions, which is largely down to price and efficacy, but when Tadalafil comes to market with the same product in a more convenient and discreet delivery mechanism, IntelGenX should see a massive number of customers take-up its services.
IntelGenx has multi-faceted BD approach for its oral films
With a burgeoning pipeline of pharmaceutical oral films, IntelGenx’s (OTCQX:IGXT; TSXV:IGX) business development strategy is focused on partnering its product pipeline along with actively meeting with potential partners to explore manufacturing
The trading setup for OREX looks very enticing. if you guys have questions you should ask AWE.some.STOCKS. They often respond to my emails which is helpful.
China Education Resources CHN V
any new catalysts for this stock in next month?
Noooooooo Voluuuuume ..... bummer Monday
Nothing special with OREX. The whole sector was in favor yesterday
Wow. looked at this company for first time in two years. Zero prospects for anything good. and a self-dealing management.